Marsdenia tenacissima extract induces endoplasmic reticulum stress-associated immunogenic cell death in non-small cell lung cancer cells through targeting AXL.

[1]  Yang Guo,et al.  Dandelion extract inhibits triple-negative breast cancer cell proliferation by interfering with glycerophospholipids and unsaturated fatty acids metabolism , 2022, Frontiers in Pharmacology.

[2]  A. M. Houghton,et al.  New Immuno-oncology Targets and Resistance Mechanisms , 2022, Current Treatment Options in Oncology.

[3]  Hui-feng Hao,et al.  Marsdenia tenacissima extract disturbs the interaction between tumor-associated macrophages and non-small cell lung cancer cells by targeting HDGF. , 2022, Journal of ethnopharmacology.

[4]  Guanzhen Yu,et al.  Extract of Marsdenia tenacissima (Roxb.) Moon [Apocynaceae] Suppresses Hepatocellular Carcinoma by Inhibiting Angiogenesis , 2022, Frontiers in Pharmacology.

[5]  Hao Cai,et al.  Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency , 2022, Advanced science.

[6]  J. Thiery,et al.  Dissecting the Role of AXL in Cancer Immune Escape and Resistance to Immune Checkpoint Inhibition , 2022, Frontiers in Immunology.

[7]  H. Hong,et al.  RNA-seq and integrated network analysis reveals the hub genes and key pathway of paclitaxel inhibition on Adriamycin resistant diffuse large B cell lymphoma cells , 2022, Bioengineered.

[8]  L. Zitvogel,et al.  Immunogenic cell stress and death , 2022, Nature Immunology.

[9]  Yanlan Hu,et al.  A Combined Phytochemistry and Network Pharmacology Approach to Reveal Potential Anti-NSCLC Effective Substances and Mechanisms in Marsdenia tenacissima (Roxb.) Moon (Stem) , 2021, Frontiers in Pharmacology.

[10]  Qilong Chen,et al.  Mechanism of protective effect of xuan-bai-cheng-qi decoction on LPS-induced acute lung injury based on an integrated network pharmacology and RNA-sequencing approach , 2020, Respiratory Research.

[11]  D. Siemann,et al.  Gas6/Axl Signaling Pathway in the Tumor Immune Microenvironment , 2020, Cancers.

[12]  H. Ditzel,et al.  AXL Targeting Abrogates Autophagic Flux and Induces Immunogenic Cell Death in Drug-Resistant Cancer Cells , 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[13]  Yu‐quan Wei,et al.  AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications , 2019, Molecular Cancer.

[14]  S. Lam,et al.  Prevention and Early Detection for Non-Small Cell Lung Cancer: Advances in Thoracic Oncology 2018. , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[15]  Jingqing Yang,et al.  Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death , 2019, Nature Communications.

[16]  Olivier Michielin,et al.  SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules , 2019, Nucleic Acids Res..

[17]  T. Okazaki,et al.  Axl kinase drives immune checkpoint and chemokine signalling pathways in lung adenocarcinomas , 2019, Molecular Cancer.

[18]  Xi Chen,et al.  The Antitumor Activities of Marsdenia tenacissima , 2018, Front. Oncol..

[19]  Xiaojian Zhang,et al.  Marsdenia tenacissima: A Review of Traditional Uses, Phytochemistry and Pharmacology. , 2018, The American journal of Chinese medicine.

[20]  F. Di Virgilio,et al.  Extracellular ATP and P2 purinergic signalling in the tumour microenvironment , 2018, Nature Reviews Cancer.

[21]  P. Agostinis,et al.  The Unfolded Protein Response in Immunogenic Cell Death and Cancer Immunotherapy. , 2017, Trends in cancer.

[22]  A. Dillin,et al.  The UPRER: Sensor and Coordinator of Organismal Homeostasis. , 2017, Molecular cell.

[23]  Wei Zhao,et al.  Marsdenia tenacissima extract overcomes Axl- and Met-mediated erlotinib and gefitinib cross-resistance in non-small cell lung cancer cells , 2017, Oncotarget.

[24]  Olivier Michielin,et al.  SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules , 2017, Scientific Reports.

[25]  L. Byers,et al.  Giving AXL the axe: targeting AXL in human malignancy , 2017, British Journal of Cancer.

[26]  M. Domingues,et al.  The Unfolded Protein Response in Homeostasis and Modulation of Mammalian Immune Cells , 2016, International reviews of immunology.

[27]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[28]  D. Schwarz,et al.  The endoplasmic reticulum: structure, function and response to cellular signaling , 2015, Cellular and Molecular Life Sciences.

[29]  M. Murphy,et al.  Redox Homeostasis and Mitochondrial Dynamics. , 2015, Cell metabolism.

[30]  T. Aittokallio,et al.  Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products. , 2015, Natural product reports.

[31]  T. Shanafelt,et al.  Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia B Cells to Apoptosis and Shows Synergistic/Additive Effects in Combination with BTK Inhibitors , 2015, Clinical Cancer Research.

[32]  Bo Zhang,et al.  Traditional Chinese medicine network pharmacology: theory, methodology and application: Traditional Chinese medicine network pharmacology: theory, methodology and application , 2014 .

[33]  L. Zerbini,et al.  The receptor tyrosine kinase Axl in cancer: Biological functions and therapeutic implications , 2014, International journal of cancer.

[34]  Shu-yan Han,et al.  Marsdenia tenacissima extract inhibits gefitinib metabolism in vitro by interfering with human hepatic CYP3A4 and CYP2D6 enzymes. , 2014, Journal of ethnopharmacology.

[35]  Uma Goyal,et al.  Untangling the web: mechanisms underlying ER network formation. , 2013, Biochimica et biophysica acta.

[36]  L. Zitvogel,et al.  Crosstalk between ER stress and immunogenic cell death. , 2013, Cytokine & growth factor reviews.

[37]  Laurence Zitvogel,et al.  Immunogenic cell death in cancer therapy. , 2013, Annual review of immunology.

[38]  Peter Vandenabeele,et al.  Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. , 2013, Immunity.

[39]  Amy S. Lee,et al.  The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies , 2013, Oncogene.

[40]  Abhishek D. Garg,et al.  Immunogenic cell death and DAMPs in cancer therapy , 2012, Nature Reviews Cancer.

[41]  G. Voeltz,et al.  Endoplasmic reticulum–mitochondria contacts: function of the junction , 2012, Nature Reviews Molecular Cell Biology.

[42]  Ming Zhao,et al.  Marsdenia tenacissima extract restored gefitinib sensitivity in resistant non-small cell lung cancer cells. , 2012, Lung cancer.

[43]  M. Wei,et al.  A new dawn for the use of traditional Chinese medicine in cancer therapy , 2009, Molecular Cancer.

[44]  P. Walter,et al.  Endoplasmic reticulum stress in disease pathogenesis. , 2008, Annual review of pathology.

[45]  Kozo Nakamura,et al.  Mechanism of Stimulation of Osteoclastic Bone Resorption through Gas6/Tyro 3, a Receptor Tyrosine Kinase Signaling, in Mouse Osteoclasts* , 2001, The Journal of Biological Chemistry.

[46]  H. Yamane,et al.  Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6 , 1995, Nature.